Single Dose Escalation First Time in Human PK Study

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

November 14, 2008

Primary Completion Date

December 7, 2009

Study Completion Date

December 7, 2009

Conditions
Infections, Bacterial
Interventions
DRUG

100 mg GSK investigational drug

DRUG

200 mg GSK investigational drug

DRUG

400 mg GSK investigational drug

DRUG

800 mg GSK investigational drug

DRUG

2000 mg GSK investigational drug

DRUG

1500 mg GSK investigational drug

DRUG

800mg fed GSK investigational drug

DRUG

3000mg GSK investigational drug

DRUG

4000mg GSK investigational drug

Trial Locations (1)

2031

GSK Investigational Site, Randwick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY